2010 Conference Engineering Finance 
N2Growth Blog
JUNE 14, 2010
While much has been written about corporate vision, mission, process, leadership, strategy, branding and a variety of other business practices, it is the engineering of these practices to be disruptive that maximizes opportunities. Has anyone on your executive team attended a conference on strategy, innovation or disruption in the last year?
Chris Brady
JANUARY 20, 2011
Example: When I was but a wee engineer just cutting my teeth in the profession, I had the good fortune to be thrown in with several elderly gentlemen who were extremely accomplished in the field. These guys were so good at technical things they actually conducted races to see who could solve complex puzzles and riddles the quickest.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Women on Business
JANUARY 24, 2011
Similarly, make sure your OWN site has the best key words for the search engines. Ten minutes reading about someone you are going to talk to can be invaluable, whether for services you consider, possible employees, collaborations to pursue, or customers to solicit. Google your name periodically. Be willing to be scattered.
N2Growth Blog
JUNE 17, 2010
In further pondering this dichotomy an interesting thought came to mind – If I could genetically engineer the perfect leadership gene what qualities and characteristics would constitute the architecture of leadership DNA? No single leader can possess every needed attribute. ” [link] lightridr Great post, Mike.
Harvard Business Review
APRIL 9, 2013
The most talented individuals in industries such as technology and finance spoke English, either as a first or second language. Imagine a conference room of individuals drawn from the far corners of the globe to work in your company or to do business with you. I began Englishnization in 2010. points in October 2010 to 737.3
Harvard Business Review
MAY 31, 2011
President Pratibha Patil has even declared 2010-2020 as India's " Decade of Innovation." For instance, in October 2010, Biocon struck a $350-million marketing alliance with Pfizer, the world's largest drug maker, to commercialize four of Biocon's insulin biosimilar products in non-overlapping markets globally. Transformers.
Harvard Business Review
JANUARY 7, 2014
I tried to get Greenspan to talk me for my November HBR article on economics and finance since the crisis , but he said he’d promised his publisher to keep mum until the book was out, which was too late for my purposes. It was the form in which the asset was financed. I finally did pay a visit to his office in D.C.
Expert insights. Personalized for you.
305 
Let's personalize your content